Agenda

Speaker presenting during an educational session at AMP 2025 in Chicago

Agenda

Explore the AMP 2026 agenda featuring expert-led education on CLTI, PAD, limb preservation, revascularization, DVA, and multidisciplinary amputation prevention strategies. Sessions include live cases, new data in CLTI, roundtable discussions, and practical treatment insights from vascular and limb preservation experts.

August 5-7, 2026 | Boston, MA

Register

August 5-7, 2026 | Boston, MA

- Speaker
  - Michael Siah MD
  - Anahita Dua MD MS MBA FACS
  - Thomas Davis MD
  - Adam Gwozdz
An Evening of Hands-On Learning, Case Discussions, Networking, and Dinner. Join us for an exclusive evening designed for trainees to explore the future of limb salvage. The program will feature hands-on sessions with LimFlow and Artix technologies, opportunities to network with expert faculty, and engaging case discussions over dinner. Sponsored by Stryker Peripheral Vascular

- Moderator
  - Richard Neville MD
  - Bret Wiechmann MD
- 8:20 AM – 8:30 AM
  
  What is the Current Definition of CLTI & PAD Today?
- 8:30 AM – 8:40 AM
  
  A Year in Review: Rapid Fire Update on CLTI Trial Publications
- 8:40 AM – 8:50 AM
  
  Promoting the Awareness of the CLTI Epidemic
- 8:50 AM – 9:00 AM
  
  The Changing Face of CLTI: Global Epidemiology and the Untold Data Story
- 9:00 AM – 9:10 AM
  
  Who Is a CLTI Operator? Building Competency in a Complex, Multidisciplinary Field
- 9:10 AM – 9:20 AM
  
  What WIFOR Data Tells Us About the Global Cost of CLTI
- 9:20 AM – 9:30 AM
  
  Including the Patient in the Decision Making Process
- 9:30 AM – 9:50 AM
  
  Discussion
- Speaker
  - Bret Wiechmann MD
- Moderator
  - Kumar Madassery MD
- 10:10 AM – 10:18 AM
  
  Utilizing Imaging to Determine to Endo Vs. Surgical Bypass First-Approach
- 10:18 AM – 10:26 AM
  
  Cross-Sectional Imaging in 2026: The New Role of PCCA and MRA in Complex Disease
- 10:26 AM – 10:34 AM
  
  Where NonInvasive Imaging Would Have Led Me Astray: The Role of Diagnositc Angiography
- 10:34 AM – 10:42 AM
  
  IVUS and EVUS: Seeing the Vessel Wall and Flow
- 10:42 AM – 10:50 AM
  
  Tissue Perfusion Imaging in CLTI
- 10:50 AM – 10:58 AM
  
  Why Simple Lesions Don’t Exist in CLTI: Imaging the Real-World Complexity Gap
- 10:58 AM – 11:06 AM
  
  Endpoints in Real World practice and in Clinical trials
- 11:06 AM – 11:31 AM
  
  Advanced Ultrasound Applications in CLTI (Live Ultrasound Demo)
- 11:31 AM – 11:50 AM
  
  Discussion
- Moderator
  - Thomas Davis MD
- 1:10 PM – 1:18 PM
  
  How Are We Defining and Valuing Vessel Prep in 2026?
- 1:18 PM – 1:26 PM
  
  Calcium Management: Tools, Timing, and Technique
- 1:26 PM – 1:34 PM
  
  Atherectomy for CLTI: Outcomes and Contemporary Data
- 1:34 PM – 1:42 PM
  
  Role of IVL as a Vessel Prep Tool
- 1:42 PM – 1:50 PM
  
  Scoring/Cutting/Plaque Modification Balloons
- 1:50 PM – 1:58 PM
  
  The Mount Sinai Experience with Coronary DES in Tibial Artery Intervention
- 1:58 PM – 2:06 PM
  
  The Impact of Retrievable Scaffold Therapy in Vessel Prep
- 2:06 PM – 2:25 PM
  
  Roundtable: BTK Revascularization: Crossing Strategy, IVUS Guidance, and Optimized Vessel Preparation
- Moderator
  - Bret Wiechmann MD
- 2:45 PM – 2:55 PM
  
  Case 1
- 2:55 PM – 3:00 PM
  
  Discussion
- 3:00 PM – 3:10 PM
  
  Case 2
- 3:10 PM – 3:15 PM
  
  Discussion
- 3:15 PM – 3:25 PM
  
  Case 3
- 3:25 PM – 3:30 PM
  
  Discussion
- 3:30 PM – 3:45 PM
  
  Conquering the CTO Roundtable
- Discussant
  - Yana Etkin MD
  - Sameh Sayfo MD, MBA, FSCAI, FACC
  - Sonya Noor MD, FACS
  - Bret Wiechmann MD
  - Fadi Saab MD
- Live Case Operator
  - Jim Joye
- Moderator
  - Khanjan Nagarsheth MD, M.B.A
Supported by an educational grant from Endologix.
- 4:55 PM – 5:02 PM
  
  Below the Knee Revascularization in CLTI: Persistent Challenges and Critical Data Gaps
- 5:02 PM – 5:09 PM
  
  Optimizing Follow Up After PTAB: Practical Insights From Early Clinical Experience
- 5:09 PM – 5:16 PM
  
  Sirolimus-Eluting Bioresorbable Scaffolds Improve Angiographic Results and Extend Patency in Complex Peripheral Arterial Disease
- 5:16 PM – 5:23 PM
  
  Treating the Toughest Lesions: Atherectomy, Drug-Coated Balloons, and Implications of the New CPT Codes
- 5:23 PM – 5:30 PM
  
  Pedal Angioplasty for Chronic Limb-Threatening Ischemia: Early Outcomes from a Multicenter Study of Serration Remodeling Therapy

- Moderator
  - Eric Scott MD
- 8:05 AM – 8:12 AM
  
  Morphology Matters: The Estimated Total and Incremental 12-month Costs of Femoropopliteal In-Stent Occlusions Versus In-Stent Stenoses
- 8:12 AM – 8:19 AM
  
  SELUTION SLR Drug-Eluting Balloon: Device Technology, Study Outcomes, and Overview of the Global Clinical Program in Peripheral Artery Disease
- 8:19 AM – 8:26 AM
  
  IVUS-Guided Femoropopliteal Interventions with Drug-Coated Devices (DCD) for PAD: Long Term Outcomes
- 8:26 AM – 8:34 AM
  
  In-Depth Analysis of DEEPER REVEAL 12-Month Data: Retrievable Stent Performance in BTK CLTI Disease
- 8:34 AM – 8:54 AM
  
  Discussion
- 8:54 AM – 9:01 AM
  
  A SEISMIQ Shift for PAD: The Latest IVL Technology for Targeted Therapy in Highly Complex Calcium
- 9:01 AM – 9:08 AM
  
  Healing That Lasts: Real-World 90-Day Outcomes Demonstrating the Durability of Serration Remodeling Therapy (SRT)
- 9:08 AM – 9:15 AM
  
  Setting the Bar: Long‑Term Efficacy Outcomes with Paclitaxel DCBs from RCTs and Registries
- 9:15 AM – 9:22 AM
  
  Santreva™-ATK: A New Paradigm in PAD Endovascular Revascularization
- 9:22 AM – 9:29 AM
  
  Long-Term Evidence from DEEPER OUS: Four-Year Outcomes of RST in Conjunction with DCB
- 9:29 AM – 9:36 AM
  
  Revascularization Strategies in CLTI: Data from the DISRUPT BTK II and How I Use Shockwave IVL to Optimize Across the BTA and BTK Segments
- 9:36 AM – 9:43 AM
  
  Cell Based Therapies for Chronic Limb Threatening Ischemia
- 9:43 AM – 10:00 AM
  
  Discussion
- Moderator
  - Jos van den Berg MD PhD
- 10:20 AM – 10:30 AM
  
  Case
- 10:30 AM – 10:37 AM
  
  This is How I Would Do It
- 10:37 AM – 10:47 AM
  
  Case
- 10:47 AM – 10:54 AM
  
  This is How I Would Do It
- 10:54 AM – 11:04 AM
  
  Case
- 11:04 AM – 11:11 AM
  
  This is How I Would Do It
- 11:11 AM – 11:21 AM
  
  Case
- 11:21 AM – 11:28 AM
  
  This is How I Would Do It
- 11:28 AM – 11:38 AM
  
  Case
- 11:38 AM – 11:45 AM
  
  This is How I Would Do It
- 11:45 AM – 12:00 PM
  
  Discussion
- Moderator
  - Marianne Brodmann MD
- 1:20 PM – 1:28 PM
  
  Bioreabsorbable BTK Update
- 1:28 PM – 1:36 PM
  
  LIMUS in 2026
- 1:36 PM – 1:44 PM
  
  Bioabsorbable Scaffolds in Below-The-Knee Arteries: Long-Term Outcomes with the MOTIV Stent
- 1:44 PM – 1:52 PM
  
  DCB and Combination Therapy: What is Available for BTK Therapy in Europe?
- 1:52 PM – 2:00 PM
  
  Below the Ankle (BTA) Intervention - What Are the Risks Involved, the Latest Evidence and When to Do it?
- 2:00 PM – 2:08 PM
  
  Retrograde Access: Primary or Alternative Approach?
- 2:08 PM – 2:30 PM
  
  Roundtable: Paclitaxel Revisited: Have We Finally Closed the Safety Debate?
- Moderator
  - John Phillips MD
- 2:50 PM – 2:57 PM
  
  CLTI Complication #1
- 2:57 PM – 3:07 PM
  
  "You Did What?" Discussion
- 3:07 PM – 3:14 PM
  
  CLTI Complication #2
- 3:14 PM – 3:24 PM
  
  "You Did What?" Discussion
- 3:24 PM – 3:31 PM
  
  CLTI Complication #3
- 3:31 PM – 3:41 PM
  
  "You Did What?" Discussion
- 3:41 PM – 3:49 PM
  
  Navigating the Conversation: Communicating with Patients and Families After a Complication
- Discussant
  - Fadi Saab MD
  - Mike Watts MD FSIR
  - Yolanda Bryce MD
  - Constantino Peña MD, FSIR
  - John Winscott MD
  - Pradeep Nair MD, FACC, FSCAI
- Moderator
  - John Phillips MD
- Discussant
  - Marianne Brodmann MD
  - Sameh Sayfo MD, MBA, FSCAI, FACC
  - Bret Wiechmann MD
  - Zola N'Dandu MD
  - Jay Mathews MD, MS, FACC, FSCAI
- Moderator
  - Eric Secemsky MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Supported by an educational grant from Angiodynamics.
- Faculty
  - Kumar Madassery MD
  - Michael Siah MD
  - Mike Watts MD FSIR
  - John Phillips MD
  - Elizabeth Genovese MD, MS, FACS, RPVI
- Room
  - Monet Room
Sponsored by Abbott Vascular.

- Moderator
  - Ahmed Kayssi MD
- 7:15 AM – 7:23 AM
  
  Spotting CLTI Before It’s Too Late: Raising Awareness with Your Referral Network
- 7:23 AM – 7:31 AM
  
  Medical Therapy in CLTI: What “Optimal Management” Means in 2026
- 7:31 AM – 7:39 AM
  
  Who Decides? Structuring Multidisciplinary Decision-Making in CLTI
- 7:39 AM – 7:47 AM
  
  The Role of Vascular Surgery in Multidisciplinary Amputation Prevention
- 7:47 AM – 7:55 AM
  
  Integrating Venous and Arterial Strategies for the Complex CLTI Patient
- 7:55 AM – 8:03 AM
  
  What Every Revascularization Specialist Should Recognize with CLTI Wounds
- 8:03 AM – 8:11 AM
  
  BEST-CLI at 4 Years: What the Long-Term Data Tells Us About Durable Limb Preservation
- 8:11 AM – 8:19 AM
  
  The Canadian Multidisciplinary Experience: How Do the Canucks Do it?
- 8:19 AM – 8:27 AM
  
  Woundosome for Wound Healing
- 8:27 AM – 8:57 AM
  
  Roundtable: From Patchwork to Protocol — Standardizing Multidisciplinary CLTI Care
- Moderator
  - Bret Wiechmann MD
- 9:00 AM – 9:08 AM
  
  Vascular Deserts and Access to Care
- 9:08 AM – 9:16 AM
  
  Hospital, ASC, or OBL in 2026 — What Really Works for CLTI?
- 9:16 AM – 9:24 AM
  
  Interpreting the New Lower-Extremity CPT Codes: Implications for Treatment of Complex CLTI Lesions with Vessel Preparation and Drug-Coated Balloons
- 9:24 AM – 9:32 AM
  
  Commercial Payor Downcoding Using AI and How Physicians Can Fight Back
- 9:32 AM – 9:40 AM
  
  Patient Experience in the Non-Hospital Site of Service
- 9:40 AM – 9:48 AM
  
  How to Fight Fire With Fire: Using AI to Optimize Reimbursement
- 9:48 AM – 9:56 AM
  
  Evolving Payment Reform and the “Office-Based Facility”: Preparing for What’s Next
- 9:56 AM – 10:15 AM
  
  Discussion
- Moderator
  - Kumar Madassery MD
- 10:55 AM – 11:03 AM
  
  Traditional Arterial Revascularization Vs. DVA Outcomes
- 11:03 AM – 11:11 AM
  
  Refining the DVA Timeline: When is DVA Too Early / Too Late?
- 11:11 AM – 11:19 AM
  
  Optimizing the Percutaneous DVA - Case Selection, Improving Technical Success and Role of Embolization
- 11:19 AM – 11:27 AM
  
  Pre-Op Mapping for DVA
- 11:27 AM – 11:35 AM
  
  My Experience with Open DVA Procedures 2026 Updates
- 11:35 AM – 11:43 AM
  
  Hybrid Superficial Venous Arterialization: preoperative planning and tips & tricks
- 11:43 AM – 11:51 AM
  
  DVA Conduit is Established: What's Next?
- 11:51 AM – 11:59 AM
  
  Failing DVA: Early Detection and Timely Reintervention Strategies
- 11:59 AM – 12:07 PM
  
  DVA Site of Service: Cost, Reimbursement, and Value
- 12:07 PM – 12:30 PM
  
  Discussion
- Discussant
  - Michael Siah MD
  - Nick Alianello
  - Kumar Madassery MD
  - Mike Watts MD FSIR
  - Jill Sommerset RVT, FSVU
  - Yana Etkin MD
  - Steven Kum MD
  - Richard Neville MD
  - Marta Lobato MD
  - Khanjan Nagarsheth MD, M.B.A
- Moderator
  - Miguel Montero-Baker MD
- 2:25 PM – 2:33 PM
  
  Distal/Plantar vs. Proximal DVA: Is There Any Difference?
- 2:33 PM – 2:41 PM
  
  Is There a Difference Between Tibial Artery Chocie for DVA: AV Vs. TV?
- 2:41 PM – 2:49 PM
  
  Case Walk-Through: Off the Shelf DVA Devices in Practice
- 2:49 PM – 2:57 PM
  
  Case Walk-Through: LimFlow System in Practice
- 2:57 PM – 3:05 PM
  
  Technical Steps for Reintervention
- 3:05 PM – 3:13 PM
  
  Importance of Plantar Venous Loop/Metatarsal vein outflow
- 3:13 PM – 3:21 PM
  
  Dealing with Venous Conduits: Role of DCB
- 3:21 PM – 3:40 PM
  
  Discussion
- Moderator
  - Fadi Saab MD
- 3:55 PM – 4:03 PM
  
  Hemodynamics & Perfusion Monitoring Technology in DVA Patients
- 4:03 PM – 4:11 PM
  
  Non-Invasive & Invasive Imaging After DVA
- 4:11 PM – 4:19 PM
  
  Venous Maturation Following DVA
- 4:19 PM – 4:27 PM
  
  Post Procedure Wound Care for DVA - What Works, What Has Failed, Lessons From the Last Decade
- 4:27 PM – 4:35 PM
  
  Complications After DVA
- 4:35 PM – 4:43 PM
  
  Unmet Needs in DVA Technology
- 4:43 PM – 4:51 PM
  
  Managing the DVA Patient: Perspectives from Down Under
- 4:51 PM – 4:59 PM
  
  Lessons Learned Throughout the DVA Evolution: Yesterday & Today
- 4:59 PM – 5:07 PM
  
  Distraction Angiogenesis in the Era of DVA: Tibial Transverse Transport and Regenerative Strategies for Ischemic Limb Salvage
- 5:07 PM – 5:25 PM
  
  Roundtable: Post-Procedure Care: Bringing the Multidisciplinary Team Together
Sponsored by Boston Scientific.